Lazard (NYSE:LAZ – Get Free Report) is expected to be announcing its earnings results before the market opens on Thursday, January 30th. Analysts expect the company to announce earnings of $0.69 per share and revenue of $793.53 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Lazard (NYSE:LAZ – Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The asset manager reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.03). The company had revenue of $646.00 million for the quarter, compared to analyst estimates of $644.22 million. Lazard had a return on equity of 42.20% and a net margin of 8.28%. The company’s revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the business earned $0.10 earnings per share. On average, analysts expect Lazard to post $2 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Lazard Price Performance
Shares of NYSE LAZ opened at $53.51 on Wednesday. The firm has a market cap of $6.03 billion, a P/E ratio of 21.32 and a beta of 1.40. The business’s 50 day moving average is $52.98 and its 200-day moving average is $50.76. The company has a current ratio of 2.24, a quick ratio of 2.24 and a debt-to-equity ratio of 2.72. Lazard has a 1-year low of $35.56 and a 1-year high of $61.14.
Analyst Ratings Changes
Read Our Latest Analysis on Lazard
Lazard Company Profile
Lazard, Inc, together with its subsidiaries, operates as a financial advisory and asset management firm in North and South America, Europe, the Middle East, Asia, and Australia. It operates in two segments, Financial Advisory and Asset Management. The Financial Advisory segment offers financial advisory services, such as mergers and acquisitions, capital markets, shareholder, sovereign, geopolitical advisory, and other strategic advisory services, as well as restructuring and liability management, and capital raising and placement services.
Read More
- Five stocks we like better than Lazard
- Top Biotech Stocks: Exploring Innovation Opportunities
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is the Hang Seng index?
- What Does the Future Hold for Eli Lilly?
- Best Aerospace Stocks Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Lazard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lazard and related companies with MarketBeat.com's FREE daily email newsletter.